BMO Capital Starts Neos Therapeutics (NEOS) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
RBC Capital Starts Neos Therapeutics (NEOS) at Outperform
August 17, 2015 7:38 AM EDTRBC Capital initiated coverage on Neos Therapeutics (NASDAQ: NEOS) with an Outperform rating and a price target of $35.00.
For an analyst ratings summary and ratings history on Neos Therapeutics click here. For more ratings news on Neos Therapeutics click here.
Shares of Neos Therapeutics closed at $20.63 yesterday.
... MoreJMP Securities Starts Neos Therapeutics (NEOS) at Market Outperform
August 17, 2015 7:37 AM EDTJMP Securities initiated coverage on Neos Therapeutics (NASDAQ: NEOS) with a Market Outperform rating and a price target of $32.00.
For an analyst ratings summary and ratings history on Neos Therapeutics click here. For more ratings news on Neos Therapeutics click here.
Shares of Neos Therapeutics closed at $20.63 yesterday.
... More